Terms: = Cervical cancer AND BCL2, Bcl-2, 596, ENSG00000171791 AND Prognosis
65 results:
1. Trifluoromethyl quinoline derivative targets inhibiting HDAC1 for promoting the acetylation of histone in cervical cancer cells.
Zhang T; Zhou C; Lv M; Yu J; Cheng S; Cui X; Wan X; Ahmad M; Xu B; Qin J; Meng X; Luo H
Eur J Pharm Sci; 2024 Mar; 194():106706. PubMed ID: 38244809
[TBL] [Abstract] [Full Text] [Related]
2. LncRNA ABHD11-AS1 activates EGFR signaling to promote cervical cancer progression by preventing FUS-mediated degradation of ABHD11 mRNA.
Yang T; Tian S; Zhao J; Pei M; Zhao M; Yang X
Cell Cycle; 2023; 22(23-24):2538-2551. PubMed ID: 38146687
[TBL] [Abstract] [Full Text] [Related]
3. Integrating pretreatment MRI-detected nodal features and Epstein-Barr virus DNA to identify optimal candidates for intensity-modulated radiotherapy alone in patients with stage II nasopharyngeal carcinoma.
Guo J; He Y; Lin C; Jiang Q; Xing HW; Zhang YC; Shen GZ; Lin HX; Guo L; Yang Q
Oral Oncol; 2023 Nov; 146():106574. PubMed ID: 37741017
[TBL] [Abstract] [Full Text] [Related]
4. Circular RNA ARHGAP5 inhibits cisplatin resistance in cervical squamous cell carcinoma by interacting with AUF1.
Deng S; Qian L; Liu L; Liu H; Xu Z; Liu Y; Wang Y; Chen L; Zhou Y
Cancer Sci; 2023 Apr; 114(4):1582-1595. PubMed ID: 36632741
[TBL] [Abstract] [Full Text] [Related]
5. Comprehensive analysis of novel prognosis-related proteomic signature effectively improve risk stratification and precision treatment for patients with cervical cancer.
Ji X; Chu G; Chen Y; Jiao J; Lv T; Yao Q
Arch Gynecol Obstet; 2023 Mar; 307(3):903-917. PubMed ID: 35713693
[TBL] [Abstract] [Full Text] [Related]
6. Prohibitin 1 interacts with p53 in the regulation of mitochondrial dynamics and chemoresistance in gynecologic cancers.
Kong B; Han CY; Kim SI; Patten DA; Han Y; Carmona E; Shieh DB; Cheung AC; Mes-Masson AM; Harper ME; Song YS; Tsang BK
J Ovarian Res; 2022 Jun; 15(1):70. PubMed ID: 35668443
[TBL] [Abstract] [Full Text] [Related]
7. Identification of novel key regulatory lncRNAs in gastric adenocarcinoma.
Razavi H; Katanforosh A
BMC Genomics; 2022 May; 23(1):352. PubMed ID: 35525925
[TBL] [Abstract] [Full Text] [Related]
8. PAX9 functions as a tumor suppressor gene for cervical cancer via modulating cell proliferation and apoptosis.
Liu J; Wang YQ; Niu HB; Zhang CX
Kaohsiung J Med Sci; 2022 Apr; 38(4):357-366. PubMed ID: 34931758
[TBL] [Abstract] [Full Text] [Related]
9. The anti-neoplastic activities of aloperine in HeLa cervical cancer cells are associated with inhibition of the IL-6-JAK1-STAT3 feedback loop.
Chen YD; Cai FY; Mao YZ; Yang YS; Xu K; Liu XF; Fan WW; Chen W; Jiang FQ; Zhang H
Chin J Nat Med; 2021 Nov; 19(11):815-824. PubMed ID: 34844720
[TBL] [Abstract] [Full Text] [Related]
10. Integrated bioinformatic analysis of miR-15a/16-1 cluster network in cervical cancer.
S S; Shukla V; Khan GN; Eswaran S; Adiga D; Kabekkodu SP
Reprod Biol; 2021 Mar; 21(1):100482. PubMed ID: 33548740
[TBL] [Abstract] [Full Text] [Related]
11. Identification of an autophagy-related gene signature for survival prediction in patients with cervical cancer.
Chen H; Deng Q; Wang W; Tao H; Gao Y
J Ovarian Res; 2020 Nov; 13(1):131. PubMed ID: 33160404
[TBL] [Abstract] [Full Text] [Related]
12. Role and mechanism of FLNa and UCP2 in the development of cervical cancer.
Wang A; Liu L; Yuan M; Han S; You X; Zhang H; Lei F; Zhang Y
Oncol Rep; 2020 Dec; 44(6):2656-2668. PubMed ID: 33125133
[TBL] [Abstract] [Full Text] [Related]
13. The Frequency of Double Expresser in Selected Cases of High Grade Diffuse Large B-Cell Lymphomas.
Naseem M; Asif M; Khadim MT; Ud-Din H; Jamal S; Shoaib I
Asian Pac J Cancer Prev; 2020 Apr; 21(4):1103-1107. PubMed ID: 32334477
[TBL] [Abstract] [Full Text] [Related]
14. Chemoradiotherapy response prediction model by proteomic expressional profiling in patients with locally advanced cervical cancer.
Choi CH; Chung JY; Kang JH; Paik ES; Lee YY; Park W; Byeon SJ; Chung EJ; Kim BG; Hewitt SM; Bae DS
Gynecol Oncol; 2020 May; 157(2):437-443. PubMed ID: 32107047
[TBL] [Abstract] [Full Text] [Related]
15. miR-140-3p impedes the proliferation of human cervical cancer cells by targeting RRM2 to induce cell-cycle arrest and early apoptosis.
Ma J; Zhang F; Sun P
Bioorg Med Chem; 2020 Feb; 28(3):115283. PubMed ID: 31902649
[TBL] [Abstract] [Full Text] [Related]
16. MiR-525-5p Repressed Metastasis and Anoikis Resistance in cervical cancer via Blocking UBE2C/ZEB1/2 Signal Axis.
Chen M; Liu LX
Dig Dis Sci; 2020 Aug; 65(8):2442-2451. PubMed ID: 31679088
[TBL] [Abstract] [Full Text] [Related]
17. Low expression of TUG1 promotes cisplatin sensitivity in cervical cancer by activating the MAPK pathway.
Wei X; Zhou Y; Qiu J; Wang X; Xia Y; Sui L
J BUON; 2019; 24(3):1020-1026. PubMed ID: 31424656
[TBL] [Abstract] [Full Text] [Related]
18. The protective role of DMBT1 in cervical squamous cell carcinoma.
Zhang CX
Kaohsiung J Med Sci; 2019 Dec; 35(12):739-749. PubMed ID: 31400059
[TBL] [Abstract] [Full Text] [Related]
19. Number of Removed Pelvic Lymph Nodes as a Prognostic Marker in FIGO Stage IB1 cervical cancer with Negative Lymph Nodes.
Wang R; Tao X; Wu X; Jiang H; Xia H
J Minim Invasive Gynecol; 2020; 27(4):946-952. PubMed ID: 31394263
[TBL] [Abstract] [Full Text] [Related]
20. Synthesis and Evaluation of Novel Cholestanoheterocyclic Steroids as Anticancer Agents.
El-Kady DS; Abd Rabou AA; Tantawy MA; Abdel-Rahman AA; Abdel-Megeed AA; AbdElhalim MM; Elmegeed GA
Appl Biochem Biotechnol; 2019 Jul; 188(3):635-662. PubMed ID: 30613863
[TBL] [Abstract] [Full Text] [Related]
[Next]
